CIKS peptide

GeneTex

CIKS peptide

9

WB: GTX26138 will completely block antibody binding in Western blot by incubating the peptide with an equal concentration of antibody for 30 minutes at 37^oC. Optimal dilutions/concentrations should be determined by the end user.

Neutralisation/Blocking

Research Use Only

0.20 mg/ml

Unconjugated

TRAF3IP2

TRAF3 interacting protein 2

ACT1, C6orf2, C6orf4, C6orf5, C6orf6, CANDF8, CIKS, PSORS13, E3 ubiquitin ligase TRAF3IP2, E3 ubiquitin-protein ligase CIKS, NFkB-activating protein ACT1, adapter protein CIKS, connection to IKK and SAPK/JNK, nuclear factor NF-kappa-B activator 1

CIKS (for connection to IKK and SAPK / JNK), also called Act 1 (for NFkappaB Activator 1), is a novel protein that associates with and activates IKK (IkappaB kinase). CIKS / Act1 also activates ATF (Activating Transcription Factor) and AP-1 (Activator Protein 1) through Jun Kinase (JNK). CIKS / Act 1 is ubiquitously expressed in human tissues.

-20°C

41116100

Human